UBS Group AG - SALARIUS PHARMACEUTICALS INC ownership

SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 23 filers reported holding SALARIUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SALARIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$8,000
-11.1%
40,848
-3.4%
0.00%
Q2 2022$9,000
+800.0%
42,285
+1591.4%
0.00%
Q1 2022$1,0000.0%2,5000.0%0.00%
Q4 2021$1,000
-85.7%
2,500
-60.9%
0.00%
Q3 2021$7,0000.0%6,400
-1.5%
0.00%
Q2 2021$7,000
-63.2%
6,500
-48.3%
0.00%
Q1 2021$19,000
+137.5%
12,579
+13.1%
0.00%
Q1 2020$8,000
+166.7%
11,123
+1178.5%
0.00%
Q4 2019$3,000
-82.4%
870
-72.2%
0.00%
Q3 2019$17,0003,1340.00%
Other shareholders
SALARIUS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
X-Square Capital, LLC 97,258$39,0000.02%
Kepos Capital LP 548,054$218,0000.02%
Virtu Financial LLC 39,476$16,0000.00%
Laird Norton Wetherby Wealth Management, LLC 39,746$16,0000.00%
SHUFRO ROSE & CO LLC 16,400$7,0000.00%
NORTHERN TRUST CORP 65,022$26,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 390,115$155,0000.00%
STATE STREET CORP 142,552$57,0000.00%
MILLENNIUM MANAGEMENT LLC 20,128$8,0000.00%
View complete list of SALARIUS PHARMACEUTICALS INC shareholders